List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharma & Cosmetics Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharma & Cosmetics Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Ointments
1.4.3 Creams
1.4.4 Gels
1.5 Market by Application
1.5.1 Global Pharma & Cosmetics Market Share by Application: 2022-2027
1.5.2 Pharmaceuticals, OTC
1.5.3 Cosmetics
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pharma & Cosmetics Market
1.8.1 Global Pharma & Cosmetics Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pharma & Cosmetics Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Pharma & Cosmetics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pharma & Cosmetics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pharma & Cosmetics Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pharma & Cosmetics Sales Volume Market Share by Region (2016-2021)
3.2 Global Pharma & Cosmetics Sales Revenue Market Share by Region (2016-2021)
3.3 North America Pharma & Cosmetics Sales Volume
3.3.1 North America Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.3.2 North America Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Pharma & Cosmetics Sales Volume
3.4.1 East Asia Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Pharma & Cosmetics Sales Volume (2016-2021)
3.5.1 Europe Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Pharma & Cosmetics Sales Volume (2016-2021)
3.6.1 South Asia Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Pharma & Cosmetics Sales Volume (2016-2021)
3.7.1 Southeast Asia Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Pharma & Cosmetics Sales Volume (2016-2021)
3.8.1 Middle East Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Pharma & Cosmetics Sales Volume (2016-2021)
3.9.1 Africa Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Pharma & Cosmetics Sales Volume (2016-2021)
3.10.1 Oceania Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Pharma & Cosmetics Sales Volume (2016-2021)
3.11.1 South America Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.11.2 South America Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Pharma & Cosmetics Sales Volume (2016-2021)
3.12.1 Rest of the World Pharma & Cosmetics Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Pharma & Cosmetics Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Pharma & Cosmetics Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pharma & Cosmetics Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pharma & Cosmetics Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pharma & Cosmetics Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pharma & Cosmetics Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pharma & Cosmetics Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pharma & Cosmetics Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pharma & Cosmetics Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pharma & Cosmetics Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pharma & Cosmetics Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pharma & Cosmetics Sales Volume Market Share by Type (2016-2021)
14.2 Global Pharma & Cosmetics Sales Revenue Market Share by Type (2016-2021)
14.3 Global Pharma & Cosmetics Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Pharma & Cosmetics Consumption Volume by Application (2016-2021)
15.2 Global Pharma & Cosmetics Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Pharma & Cosmetics Business
16.1 Johnson & Johnson
16.1.1 Johnson & Johnson Company Profile
16.1.2 Johnson & Johnson Pharma & Cosmetics Product Specification
16.1.3 Johnson & Johnson Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Roche
16.2.1 Roche Company Profile
16.2.2 Roche Pharma & Cosmetics Product Specification
16.2.3 Roche Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Novartis
16.3.1 Novartis Company Profile
16.3.2 Novartis Pharma & Cosmetics Product Specification
16.3.3 Novartis Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Pfizer
16.4.1 Pfizer Company Profile
16.4.2 Pfizer Pharma & Cosmetics Product Specification
16.4.3 Pfizer Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Sanofi
16.5.1 Sanofi Company Profile
16.5.2 Sanofi Pharma & Cosmetics Product Specification
16.5.3 Sanofi Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Eli Lilly
16.6.1 Eli Lilly Company Profile
16.6.2 Eli Lilly Pharma & Cosmetics Product Specification
16.6.3 Eli Lilly Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 GSK
16.7.1 GSK Company Profile
16.7.2 GSK Pharma & Cosmetics Product Specification
16.7.3 GSK Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Bayer
16.8.1 Bayer Company Profile
16.8.2 Bayer Pharma & Cosmetics Product Specification
16.8.3 Bayer Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Merck & Co
16.9.1 Merck & Co Company Profile
16.9.2 Merck & Co Pharma & Cosmetics Product Specification
16.9.3 Merck & Co Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 L OREAL
16.10.1 L OREAL Company Profile
16.10.2 L OREAL Pharma & Cosmetics Product Specification
16.10.3 L OREAL Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Unilever
16.11.1 Unilever Company Profile
16.11.2 Unilever Pharma & Cosmetics Product Specification
16.11.3 Unilever Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Procter & Gamble
16.12.1 Procter & Gamble Company Profile
16.12.2 Procter & Gamble Pharma & Cosmetics Product Specification
16.12.3 Procter & Gamble Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Estee Lauder
16.13.1 Estee Lauder Company Profile
16.13.2 Estee Lauder Pharma & Cosmetics Product Specification
16.13.3 Estee Lauder Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Kao
16.14.1 Kao Company Profile
16.14.2 Kao Pharma & Cosmetics Product Specification
16.14.3 Kao Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Shiseido
16.15.1 Shiseido Company Profile
16.15.2 Shiseido Pharma & Cosmetics Product Specification
16.15.3 Shiseido Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Beiersdorf
16.16.1 Beiersdorf Company Profile
16.16.2 Beiersdorf Pharma & Cosmetics Product Specification
16.16.3 Beiersdorf Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Henkel
16.17.1 Henkel Company Profile
16.17.2 Henkel Pharma & Cosmetics Product Specification
16.17.3 Henkel Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Shanghai Jahwa
16.18.1 Shanghai Jahwa Company Profile
16.18.2 Shanghai Jahwa Pharma & Cosmetics Product Specification
16.18.3 Shanghai Jahwa Pharma & Cosmetics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Pharma & Cosmetics Manufacturing Cost Analysis
17.1 Pharma & Cosmetics Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pharma & Cosmetics
17.4 Pharma & Cosmetics Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pharma & Cosmetics Distributors List
18.3 Pharma & Cosmetics Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pharma & Cosmetics (2022-2027)
20.2 Global Forecasted Revenue of Pharma & Cosmetics (2022-2027)
20.3 Global Forecasted Price of Pharma & Cosmetics (2016-2027)
20.4 Global Forecasted Production of Pharma & Cosmetics by Region (2022-2027)
20.4.1 North America Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.3 Europe Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.7 Africa Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.9 South America Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Pharma & Cosmetics Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Pharma & Cosmetics by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pharma & Cosmetics by Country
21.2 East Asia Market Forecasted Consumption of Pharma & Cosmetics by Country
21.3 Europe Market Forecasted Consumption of Pharma & Cosmetics by Countriy
21.4 South Asia Forecasted Consumption of Pharma & Cosmetics by Country
21.5 Southeast Asia Forecasted Consumption of Pharma & Cosmetics by Country
21.6 Middle East Forecasted Consumption of Pharma & Cosmetics by Country
21.7 Africa Forecasted Consumption of Pharma & Cosmetics by Country
21.8 Oceania Forecasted Consumption of Pharma & Cosmetics by Country
21.9 South America Forecasted Consumption of Pharma & Cosmetics by Country
21.10 Rest of the world Forecasted Consumption of Pharma & Cosmetics by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer